About
Resistell develops an ultra-rapid phenotypic antibiotic susceptibility testing platform using nanomotion technology to significantly reduce the time to determine effective antibiotic treatments from days to about one hour.
Explore Resistell Ag's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.